Dopamine receptor in hypertension with Polycystic Kidney Disease
Phase 2
- Conditions
- Adult Polycystic Kidney Disease.Polycystic kidney, autosomal dominant Polycystic kidney, adult type
- Registration Number
- IRCT2012110611384N1
- Lead Sponsor
- The Dean, College of Pharmacy, University of Baghdad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
adult type polycystic kidney disease with borderline hypertension; Control group inclusion criteria are essential borderline hypertension without any secondary cause.
Exclusion criteria are: Pregnancy, lactation, diabetes mellitus, myocardial infarction, angina, arrhythmias, renal transplantation, renal failure, serum creatinin more than 3mg/dL, dialysis, sever hypertension, recieving antihypertensive drugs.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood Pressure. Timepoint: 0 hour, 2 hours, 7 days. Method of measurement: mercury sphygmomanometer.;Serum Nitric Oxide. Timepoint: 0 hour, 7 days. Method of measurement: serum detection by Greiss reaction (colorimetric).
- Secondary Outcome Measures
Name Time Method